|« Previous month||Next month »|
31-Oct-2012 - Lonza says it will cut jobs at its facility in Visp, Switzerland and that it may enact ‘similar productivity improvement programmes’ at other facilities.
31-Oct-2012 - The full impact of Superstorm Sandy is still being assessed, but early reports suggest that the East coast contract manufacturing industry has escaped relatively unscathed.
31-Oct-2012 - SAFC will provide pre-formulation services for South Korea-based NSAID developer CrystalGenomics.
30-Oct-2012 - Cyprotex has signed an 18-month collaboration with US drug giant Pfizer focused on predictive in-vitro toxicology in preclinical development.
30-Oct-2012 - French contract research organisation (CRO) Biotrial will buy Warnex’s bioanalytical services business for C$6m before the end of the year.
29-Oct-2012 - Canadian CMO Patheon will buy softgel specialist Banner Pharmacaps, moving forward with its plan to build in the oral dose delivery sector.
29-Oct-2012 - Lonza claims a new selection technology to its microbial protein expression system will improve yields and boost efficiency.
29-Oct-2012 - Outsourcing-pharma.com presents a roundup of contract manufacturing news with deals for Lonza, DSM and Ark Therapeutics and an expanded agreement with Shire for AMRI.
25-Oct-2012 - CMO Cobra Biologics says North America is an obvious place to look at for a facility acquisition.
25-Oct-2012 - Ukraine hopes changes to import laws will help cut trial start-up time from six month to 45 days.
25-Oct-2012 - Outsourcing-Pharma.com presents its weekly round-up of the latest appointments within the industry, including news from Quintiles, AMRI and PDI.
24-Oct-2012 - Fujifilm Diosynth Biotechnologies has partnered with Piramal Healthcare on development and manufacture of ADCs.
24-Oct-2012 - Discovery of the genetic basis for the placebo effect in IBS patients has wider implications for protocol design and trials of personalised medicines say researchers.
24-Oct-2012 - Quintiles has established roots in Indonesia through a new partnership with Prodia.
24-Oct-2012 - Penn Pharma is in talks with a number of “big players” over its upcoming high containment oral solid dose facility.
23-Oct-2012 - The EMA has issued new guidance on the publication of clinical trial results as part of an effort to make such data publicly available.
23-Oct-2012 - The Drug Regulatory Authority of Pakistan has set up a committee to resolve registration and licensing issues with local contract manufacturers.
23-Oct-2012 - Xcelience is shopping for a European distributor after opening a new clinical trial supply facility in the US.
23-Oct-2012 - Cobra Biologics says former Lonza biopharmaceutical science officer brings strategic insight, process development and manufacturing expertise.
22-Oct-2012 - Catalent says making its technology available to industry will not affect its competitive edge.
22-Oct-2012 - Wuxi AppTec has opened a biologics manufacturing facility that will play a key role in its recent accord with Anglo-Swedish drugmaker AstraZeneca.
22-Oct-2012 - Preclinical services firm SNBL USA has gained AAALAC accreditation for animal research programs at its sites in Everett, Washington and Alice, Texas.
18-Oct-2012 - US CMO Ben Venue has restarted 'limited drug manufacturing' at its plant in Bedford, Ohio, but does not expect to start shipping product for several months.
18-Oct-2012 - Catalent has established a new institute in a bid to advance drug delivery by creating links between industry and academia.
18-Oct-2012 - Outsourcing-Pharma.com presents its weekly round-up of the latest changes, faces and places in the pharma services sector, including news from Wolters, Advanced Clinical and BIA.
|« Previous month||Next month »|